The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sasanlimab as bladder-sparing maintenance treatment after neoadjuvant chemotherapy in patients with muscle invasive bladder cancer (MIBC): The phase 2, SASAN-SPARING trial.
 
Elena Sevillano
Honoraria - Astellas Pharma; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi
Research Funding - Pfizer
 
Julia Martinez Perez
No Relationships to Disclose
 
Nuria Lainez Milagro
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; MSD
Speakers' Bureau - Ipsen; Merck; MSD
 
Pablo Gajate Borau
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Merck; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; IPSEN; Merck; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Ipsen; Merck; Pfizer; Roche
 
Xavier Garcia del Muro
Honoraria - Ipsen
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Deciphera; Eisai; Ipsen; Merck; MSD; Pfizer; PharmaMar; Recordati; Roche
Speakers' Bureau - Astellas Pharma; Eisai; Pfizer; Recordati
Research Funding - AstraZeneca; Incyte
Travel, Accommodations, Expenses - AstraZeneca Spain; Merck; Pfizer
 
Javier Puente
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Merck (Inst); Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; Merck Serono; MSD Oncology; Pfizer; Roche
 
Miguel Angel Climent
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai Europe; EUSA Pharma; Ipsen; Janssen; Merck; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Janssen Oncology; Janssen-Cilag; Merck; MSD Oncology; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen; Merck; MSD Oncology; Pfizer; Roche
 
Alfonso Gomez de Liaño
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Johnson & Johnson/Janssen; Merck KGaA; MSD; Pfizer; Recordati
Consulting or Advisory Role - AAA HealthCare; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Johnson & Johnson/Janssen; Merck; MSD; Novartis
Research Funding - AstraZeneca (Inst); Genmab (Inst); Gilead Sciences (Inst); Janssen (Inst); Medsir (Inst); Merck KGaA (Inst); MSD (Inst); Roche (Inst); Syneos Health (Inst)
Travel, Accommodations, Expenses - Ipsen; Merck; MSD; Pfizer
 
Oscar Reig Torras
Stock and Other Ownership Interests - Bristol Myers Squibb; Merck; Pfizer
Honoraria - Astellas Pharma; BMS; Ipsen; Merck; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Sanofi
Travel, Accommodations, Expenses - Ipsen; Merck
 
Guillermo de Velasco
Honoraria - Astellas Pharma; BMS; Ipsen; Pfizer
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Ipsen; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Pierre Fabre; Roche
Research Funding - Ipsen
Travel, Accommodations, Expenses - BMS; BMS; Roche